SomnoMed

SomnoMed is a medical device company headquartered in Plano, Texas. The company employs 35 people and generates approximately $20 million in annual revenue. Founded in 2004, SomnoMed is publicly traded on the Australian Stock Exchange. SomnoMed specializes in the development and manufacture of oral appliances for the treatment of Obstructive Sleep Apnea (OSA). Their devices are custom-made using advanced technology, ensuring precision, comfort, and a first-time fit for patients. SomnoMed's products have received 510(k) clearance from the FDA, TGA listing, and are manufactured according to ISO 13485 quality standards. SomnoMed distinguishes itself by focusing on providing comfortable and effective OSA treatment. Their commitment to continuous improvement has resulted in oral sleep medicine devices that are increasingly effective and comfortable. Over 625,000 patients worldwide have benefited from SomnoMed's treatments for mild to moderate OSA. To learn more about SomnoMed's products and services, visit their website at somnomed.com.